Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of congenital disorders of lipid metabolism, caused by loss of the normal peroxisomes. Signs and symptoms include developmental delays, intellectual disability, characteristic facial dysmorphic features, hepatomegaly, and hypotonia.
Biomarker and diagnostic research for peroxisomal disease has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
199 publications have been identified in PubMed for peroxisomal disease. Research spans Basic Science / Preclinical (51%), Review / Meta-Analysis (24%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 101 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 48 | 24% |
Patient case studies | 29 | 15% |
New treatment approaches | 10 | 5% |
Disease patterns and progression | 4 | 2% |
Clinical study results | 3 | 2% |
Other research | 2 | 1% |
Testing and diagnosis research | 2 | 1% |
Diaz-Moreno U (2026). [PMID: 41367148](https://pubmed.ncbi.nlm.nih.gov/41367148/). *Journal of inherited metabolic disease*. [Case Report / Case Series]
Gao XD (2026). [PMID: 41981313](https://pubmed.ncbi.nlm.nih.gov/41981313/). *Nat Biomed Eng*. [Basic Science / Preclinical]
Lu P (2026). [PMID: 41638276](https://pubmed.ncbi.nlm.nih.gov/41638276/). *Int J Biol Macromol*. [Diagnostic / Biomarker]
Clague MJ (2026). [PMID: 41474611](https://pubmed.ncbi.nlm.nih.gov/41474611/). *J Cell Biol*. [Basic Science / Preclinical]
Zhang J (2026). [PMID: 41400028](https://pubmed.ncbi.nlm.nih.gov/41400028/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Liu Z (2026). [PMID: 41507665](https://pubmed.ncbi.nlm.nih.gov/41507665/). *Nat Metab*. [Basic Science / Preclinical]
Kumar R (2026). [PMID: 32809453](https://pubmed.ncbi.nlm.nih.gov/32809453/). *Unknown Journal*. [Other]
Barnes-Vélez JA (2026). [PMID: 41196656](https://pubmed.ncbi.nlm.nih.gov/41196656/). *J Clin Invest*. [Basic Science / Preclinical]
Elumalai V (2026). [PMID: 32809511](https://pubmed.ncbi.nlm.nih.gov/32809511/). *Unknown Journal*. [Basic Science / Preclinical]
Guerreiro G (2026). [PMID: 42068145](https://pubmed.ncbi.nlm.nih.gov/42068145/). *Int J Dev Neurosci*. [Diagnostic / Biomarker]